RMBS

Rambus Inc. 2007 Annual Report (10-K) Summary

Business Context and Reporting Period

This summary covers the fiscal year ended December 31, 2007. Rambus Inc. designs, develops, and licenses chip interface technologies and architectures for computing, communications, and consumer electronics. The company operates in a single segment and derives the majority of its revenue from patent licensing royalties and product licensing (including engineering services). As of year-end, Rambus held over 680 issued patents and had approximately 540 pending applications.

Key Financial Metrics

Revenue Composition (2007): Royalties accounted for 85.8% of total revenue ($154.3 million), while contract revenues accounted for 14.2% ($25.6 million). International revenues represented approximately 85% of total revenue.

Material Changes vs. Prior Period

• Revenue Decline: Total revenue decreased 7.9% to $179.9 million, driven primarily by an 8.6% drop in royalty revenues. This was attributed to decreased revenue from AMD, Qimonda, and NEC, partially offset by increases from Toshiba and Fujitsu. The expiration of the Intel patent cross-license agreement in 2006 eliminated a significant revenue stream present in prior years.
• Net Loss Expansion: The net loss widened to $27.7 million from $13.8 million in 2006. This was caused by increased operating expenses, specifically higher Research and Development (R&D) costs ($82.9 million vs. $69.0 million) and Marketing, General, and Administrative (MG&A) expenses ($120.6 million vs. $104.6 million).
• Restatement Costs: Costs related to the stock option investigation and financial restatement decreased to $19.5 million in 2007 from $31.4 million in 2006. The 2006 figure included a one-time $18.0 million accrual for a class action settlement.
• Debt Status: In 2006, $160 million in convertible notes were classified as current liabilities due to a default notice regarding SEC filing delays. In 2007, after becoming current with filings and receiving a waiver from the trustee, the notes were reclassified as long-term liabilities.

Guidance, Outlook, Risks, and Contingencies

Management Commentary & Outlook: Management expects R&D and engineering expenses to continue increasing in absolute dollars to maintain leadership in chip interface technologies. The company anticipates continued revenue concentration in a limited number of licensees. Royalties from RDRAM are expected to decline as the product approaches end-of-life, while XDR and FlexIO royalties are expected to vary based on licensee shipment volumes (e.g., Sony PlayStation 3).

Key Risks and Contingencies:

• Intellectual Property Litigation: Rambus faces significant litigation risks regarding its JEDEC participation and patent enforcement. The Federal Trade Commission (FTC) issued an order in February 2007 limiting royalty rates for certain SDR and DDR SDRAM products. As of year-end, $2.4 million in potential revenue was excluded due to this order. The company is appealing the FTC decision.
• Stock Option Investigation: The company is subject to shareholder derivative and class-action lawsuits related to historical stock option granting practices. A $18.0 million settlement was agreed upon in principle for the class action. Additional legal costs and indemnification obligations for officers and directors remain a risk.
• Internal Controls: Management identified a material weakness in internal control over financial reporting due to insufficient personnel with appropriate accounting knowledge and training. Remedial actions, including hiring new finance leadership, were initiated in late 2007.
• Customer Concentration: The top five licensees represented approximately 67% of 2007 revenues. Loss of any major licensee (e.g., Fujitsu, Elpida, Qimonda, Toshiba) would substantially impact results.

Investor Verification Checklist

• FTC Appeal Outcome: Verify the status of the appeal against the FTC's royalty rate caps, as this directly impacts future royalty revenue recognition.
• Qimonda Settlement Trigger: Confirm whether new licenses with other DRAM manufacturers have been secured to trigger the additional $100 million potential royalty payments from Qimonda, which ceased in Q1 2008.
• Internal Control Remediation: Assess the effectiveness of the new finance personnel and processes in addressing the material weakness in internal controls.
• Restatement Litigation Costs: Monitor actual legal expenses and settlement payments related to the stock option investigation against the accrued $18 million and other estimates.
• Convertible Note Covenants: Ensure continued compliance with SEC reporting covenants to prevent future acceleration of the $160 million debt obligation.